Co-delivery of vincristine and quercetin by nanocarriers for lymphoma combination chemotherapy

Abstract Purpose Chemotherapy is the current standard treatment for Non-Hodgkin’s lymphoma (NHL). Combination therapy is emerging as an important strategy for a better long-term prognosis with decreased side effects, maximized therapeutic effect. The aim of this study is to deliver vincristine ( VCR...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Biomedicine & pharmacotherapy 2017-07, Vol.91, p.287-294
Hauptverfasser:	Zhu, Baomin, Yu, Lianling, Yue, QingCai
Format:	Artikel
Sprache:	eng
Schlagworte:	Animals Antineoplastic Combined Chemotherapy Protocols - administration & dosage Antineoplastic Combined Chemotherapy Protocols - therapeutic use Cell Death - drug effects Cell Line, Tumor Cell Proliferation - drug effects Disease Models, Animal Drug Carriers - chemistry Drug Liberation Drug resistance Humans Internal Medicine Lipids - chemistry Lymphoma Lymphoma - drug therapy Lymphoma - pathology Male Medical Education Mice, Inbred BALB C Nanoparticles - chemistry Non-Hodgkin lymphoma Plasma Quercetin Quercetin - administration & dosage Quercetin - pharmacology Quercetin - therapeutic use Tissue Distribution - drug effects Vincristine Vincristine - administration & dosage Vincristine - pharmacology Vincristine - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!